The firm information that the product was reporting false positive results
Source facts
Action
On January 20, 2017, the firm sent Urgent Medical Device Recall notification letter and response form to their customers. The letter identified the affected and the reason for the recall. Users are instructed not to use any Blastomyces dermatitidis (catalog # 200265) that they may have in inventory and to quarantine any affected product. Return any affected product per the instructions provided; and, complete and return the attached acknowledgement form. Questions regarding this recall should be directed to Penny Epperson, Quality Manager, at 859-303-5169 or pepperson@gibsonlabs.com.
Initiated
2017-01-20
Root cause
Mixed-up of materials/components
Terminated
2018-02-20
Distribution
Distributed to the states of AL, AZ & MS.
Recall number
Z-0606-2018
Recall status
Terminated
CDRH record ID
160239
FDA record created
2018-02-14
Recall event number
78731
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.